GALAXIES PHARMACEUTICALS OÜ

Media page and news feed
?
Connected with quality, repeatability and regulatory compliance. Complete laboratory analysis and development of adapted pharmaceutical formulations ensure that

Complete laboratory analysis and development of pharmaceutical formulations - reliable quality control and validated production processes

Connected with quality, repeatability and regulatory compliance. Complete laboratory analysis and development of adapted pharmaceutical formulations ensure that the performance and safety of the product meet both the requirements of the clinical and manufacturing environment.

What service covers

Provides comprehensive laboratory analysis and testing , extensive quality control and analysis and targeted medical formulations development . Work also includes the validation of production processes in order to confirm the replicability of processes and support regulatory approval. Testing methods are validated, monitored and documented in accordance with international standards.

For anyone this is

Services are suitable for pharmaceutical and biotechnology companies, manufacturers of medical devices, control manufacture organisations (CMOs) and regulatory advisory teams that need sound quality and risk management. Suitable for start-up development groups as well as for products in the production phase requiring validation prior to placing on the market.

Principal functions and services

  • Laboratory analysis and testing: chemical, physico-chemical and microbiological tests, stability analysis and validation of methods.
  • Quality control and analysis: batch control, end product testing, preservation and configuration assessment.
  • Ravimformula development: optimised forms, release profiles and scalized prescriptions to ensure a consistent effect and safety
  • li>
  • <<Confirmation of production processes:, process suitability, Quality laboratory analysis and testing ensures the reliability of the products and helps to detect and eliminate variations before large-scale production. The development

    Main advantages

    • Reduced risk of recall and detection of operational errors at an early stage improves the patient's resilience and experience, while the validation
    • of production processes confirms that the processes are repeated and comply with regulatory requirements.

      Main advantages

    • Reduced solutions suitable for both prototypes and production lines.
    • /ul>

      Erival and competitive advantage

      Integrated approach combines scientific precision and practical production experience: development team works with laboratories to smoothly transfer formulations to full-scale production. Automated test flows and rigorous quality management ensure a rapid result without compromises in precision.

      Call for action: Contact us if the aim is to achieve reliability, regulatory compliance and repetition of production processes - together you can create tested, validated and market-compliant solutions.

Comments (0)


Are you sure you want to delete this article?

Dropdown

all articles

Reliable sterile and scalable production of biological medicinal products

The production of biological medicines   requires precision, control and flexibility - every step must ensure safety and the stability of active substances. The
ssb.ee
The production of biological medicines requires precision, control and flexibility - every step must ensure safety and the stability of active substances. The proposed solution combines modern clean infrastructure and research-based processes to deliver sterile and scalable biotechnological solutions in different forms of dosage. Systematic quality management and strict regulatory compliance ensure a result that supports market entry and patient safety. For whom Service is suitable for pharmaceutical companies, biotechnology start-ups, clinical trial partners and contrast manufacturers

GMP-level gene vector production: purity, stability and regulatory certainty for placing gene therapy medicinal products on the market

Overview   GMP compliant production  focuses on the production of high-quality gene vectors and gene therapy medicinal products that support both clinical trial
ssb.ee
Overview GMP compliant production focuses on the production of high-quality gene vectors and gene therapy medicinal products that support both clinical trials and commercial production. The services are designed to develop genetic treatments by providing a scalable, safe and reproducible production solution that reduces development risks and speeds up the time line to reach the market. Who benefits? The services are suitable for biotechnology companies, pharmaceutical companies, research laboratories and start-up teams that require reliable production of gen vectors for the clinical

Complete pharmaceutical production - fast pharmaceutical product development and production of biological medicinal products that meet GMP requirements

Healthy pharmaceutical production  combines scientific precision and industrial performance in order to bring drug development from the idea to the clinical pha
ssb.ee
Healthy pharmaceutical production combines scientific precision and industrial performance in order to bring drug development from the idea to the clinical phase and to the market faster and safer. The services cover the entire value chain: pharmaceutical product development, formulations, production of biological medicines and full quality control and analysis - all according to GMP compliant production . What does this mean for production and development? Integrated approach reduces transition, shorter timetables ensure lower risk and better cost-effectiveness. In combination with a

Are you sure you want to delete this article?

Loader

Loader

App Ad

Scorestorybook Chrome extension

The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.